- Category
- Micro (2020-21)
- Udyam number
- UDYAM-RJ-17-0039363

Delmas Pharmaceuticals Private Limited
About Delmas Pharmaceuticals Private Limited
Data last updated:
Delmas Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U33100RJ2021PTC072862. Its GSTIN is 09AAICD2423R1Z7 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anuj Kumar and Ashutosh Gaur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 255 – A RIICO Mansarovar, Jaipur, Rajasthan, India – 302020.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.12 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹6,210 (net margin 0.5%) and EBITDA of ₹10,840 (EBITDA margin 0.8%).
Delmas Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0039363).
Company details
Recognitions & Rankings of Delmas Pharmaceuticals
Contact details
Delmas Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered AddressF – 255 – A RIICO Mansarovar, Jaipur, Rajasthan, India – 302020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Delmas Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Delmas Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Delmas Pharmaceuticals Private Limited, buy the company report.
Financials of Delmas Pharmaceuticals Private Limited
FY 2025 filings availableDelmas Pharmaceuticals Private Limited reported revenue of ₹13.12 Lakh (up 13% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 13% in the latest year. EBITDA fell 83% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹10,840 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹6,210 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.8% | |||
| Net Profit Margin | 0.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Delmas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Delmas Pharmaceuticals Private Limited
Delmas Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuj Kumar | Director | 08 Jan 2021 | 5 Years 10 Months | Current |
| Ashutosh Gaur | Director | 08 Jan 2021 | 5 Years 10 Months | Current |
Peer comparison
Delmas Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| KBD Pharmaceuticals Private Limited | ₹13.15 Lakh (FY 2023) | 10.0% | Hyderabad, Telangana, India | |||
| Kestrel Pharmaceuticals Private Limited | ₹13.14 Lakh (FY 2025) | -26.0% | Jail Road, Kerala, India | |||
| Sridhara Life Sciences Private Limited | ₹13.13 Lakh (FY 2021) | -98.0% | Indore, Madhya Pradesh, India | |||
| Delmas Pharmaceuticals Private Limitedthis company | ₹13.12 Lakh (FY 2024) | ₹6,210 | 0.5% | 13.0% | Jaipur, Rajasthan, India | |
| Gynus Pharmaceuticals Private Limited | ₹13.1 Lakh (FY 2025) | 0.0% | Allahabad, Uttar Pradesh, India | |||
| Indu Pharma Private Limited | ₹13.1 Lakh (FY 2019) | 8.0% | Balanagar, Hyderabad - 37, Andhra Pradesh, India |
To see the full peer comparison of Delmas Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Delmas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Delmas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Delmas Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICD2423R1Z7 | Uttar Pradesh | Active | 02 Aug 2021 |
To see the full GST registrations and return filing status of Delmas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Delmas Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Anuj Kumar was appointed as Director on 08 Jan 2021.
Frequently asked questions
Delmas Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 January 2021 (5+ years old) and is registered under CIN U33100RJ2021PTC072862.
Delmas Pharmaceuticals has 2 current directors:
- Anuj Kumar - Director
- Ashutosh Gaur - Director
The latest financial statements of Delmas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Delmas Pharmaceuticals is 09AAICD2423R1Z7, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Delmas Pharmaceuticals is U33100RJ2021PTC072862. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Delmas Pharmaceuticals was incorporated on 08 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Delmas Pharmaceuticals by revenue are KBD Pharmaceuticals Private Limited, Kestrel Pharmaceuticals Private Limited, Sridhara Life Sciences Private Limited, Gynus Pharmaceuticals Private Limited, Indu Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anuj Kumar was appointed as Director on 08 Jan 2021. Ashutosh Gaur was appointed as Director on 08 Jan 2021.
Yes, Delmas Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0039363).
The registered office of Delmas Pharmaceuticals is at F – 255 – A RIICO Mansarovar, Jaipur, Rajasthan, India – 302020.
Delmas Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

